HCPLive

Product News

Latest

Nasal Powder for Migraine Relief Gets FDA Approval
The FDA has approved sumatriptan nasal powder (Onzetra Xsail/Avanir Pharmaceuticals) for treating of adults suffering from acute migraines with or without aura.
Hep C Drug Approved for Genotypes 1 and 4
The US Food and Drug Administration has approved a combination of elbasvir and grazoprevir (Zepatier/Merck) for treatment of adults with chronic hepatitis C infection.
Lung Drug Gets FDA Approval
The US Food and Drug Administration approved selexipag (Uptravi/Actelion Pharmaceuticals US) for treatment of pulmonary arterial hypertension (PAH) in adults.
FDA Approves Nasal Spray Naxolone
An easy-to-use nasal-spray version of naxolone hydrochloride (Narcan) got rapid FDA approval. It is available only by prescription, but requires no medical training to administer.
FDA Approves HIV Combo Tablet
The FDA approved a new combination tablet that provides once-a-day dosing for patients with HIV-1 infection.
FDA Approves Asthma Add-On Treatment
Asthma treatment approved as "add-on" for patients with severe asthma.
Hypertension Combo Treatment Approved
The US Food and Drug Administration today approved combining ambrisentan (Letairis/Gilead) with tadalafil to treat pulmonary arterial hypertension.
New Stent Approved
The FDA approved a new bioabsorbable polymer drug-eluting stent system for coronary artery disease.
FDA Approves Diabetes Drugs
The FDA today approved two new diabetes drugs. The agency gave the nod to insulin degludec injection (Tresiba/Novo Nordisk) and insulin degludec/insulin aspart (Ryzodeg/Novo Nordisk)

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$